Pluristem Therapeutics Inc., of Haifa, Israel, and the Berlin-Brandenburg Center for Regenerative Therapies, in cooperation with the Charite-University of Medicine in Berlin, reported positive results from a preclinical study demonstrating that local administration of Pluristem's PLX cells following muscle injury resulted in significant improvement in the recovery of muscle function when compared with the control group. Study data indicated PLX cells can be used in accidental injuries, such as athletic injuries, as well as intentional injuries, such as the incision of skeletal muscle during surgery.